TerminatedPhase 2NCT01617733
Pasireotide Therapy in Patients With Nelson's Syndrome
Studying Nelson syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Principal Investigator
- John Newell-PriceSheffield Teaching Hospitals NHS Foundation Trust
- Intervention
- Pasireotide(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2011 – 2015
Study locations (4)
- Barts and the London NHS Trust, London, United Kingdom
- The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
- Oxford University Hospitals NHS Trust, Oxford, United Kingdom
- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
Collaborators
Novartis · The Christie NHS Foundation Trust · Oxford University Hospitals NHS Trust · Barts & The London NHS Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01617733 on ClinicalTrials.gov